This story has been updated to reflect that MDxHealth completed its private placement on June 29.

NEW YORK (GenomeWeb News) – MDxHealth has successfully completed a private placement that raised €10 million ($12.4 million).

Pursuant to the placement, the Belgian molecular diagnostics firm said it will issue about 2 million new ordinary shares to Bioinvest Comm. at an offer price of €1.503 and 4.9 million shares to other unnamed investors at an offer price of €1.430.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.